TrialClinical pharmacokinetics2019

Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis.

Amit Khatri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.